Triple

T3849413
Position Surface form Disambiguated ID Type / Status
Subject Center for Drug Evaluation and Research E85252 entity
Predicate oversees P46 FINISHED
Object Office of Translational Sciences
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
E392787 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Office of Translational Sciences | Statement: [Center for Drug Evaluation and Research, oversees, Office of Translational Sciences]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Office of Translational Sciences
Context triple: [Center for Drug Evaluation and Research, oversees, Office of Translational Sciences]
  • A. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • B. Division of Extramural Research
    The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
  • C. Center for Scientific Review
    The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
  • D. Center for Health and Biosciences
    The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
  • E. Division of Intramural Research
    The Division of Intramural Research is the National Heart, Lung, and Blood Institute’s in-house research arm that conducts basic, translational, and clinical studies on cardiovascular, pulmonary, and blood-related diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Office of Translational Sciences
Triple: [Center for Drug Evaluation and Research, oversees, Office of Translational Sciences]
Generated description
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Office of Translational Sciences
Target entity description: The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
  • A. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • B. Division of Extramural Research
    The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
  • C. Center for Scientific Review
    The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
  • D. Center for Health and Biosciences
    The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
  • E. Division of Intramural Research
    The Division of Intramural Research is the National Heart, Lung, and Blood Institute’s in-house research arm that conducts basic, translational, and clinical studies on cardiovascular, pulmonary, and blood-related diseases.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed936de1c81908f91bed80f70abb2 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69aeebcde86081908cf3840ae002acfa completed March 9, 2026, 3:48 p.m.
NED1 Entity disambiguation (via context triple) batch_69b504172d58819089d19f5cb7b803ec completed March 14, 2026, 6:45 a.m.
NEDg Description generation batch_69b504f32da48190a561cc72f0c4e827 completed March 14, 2026, 6:49 a.m.
NED2 Entity disambiguation (via description) batch_69b5064192a48190a0f95dee872437e0 completed March 14, 2026, 6:54 a.m.
Created at: March 9, 2026, 3:19 p.m.